context stringlengths 21 24.6k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 168 |
|---|---|---|---|---|---|
As of December 31, 2022, Notes due 2036 consisted of a $ 32 million secured term loan (the “Agemo Term Loan”) and a $ 25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016 and bore interest at 9 % per annum. The Agemo Term Loan had a maturity date of Decemb... | text | 32 | monetaryItemType | text: <entity> 32 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2022, Notes due 2036 consisted of a $ 32 million secured term loan (the “Agemo Term Loan”) and a $ 25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016 a... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
As of December 31, 2022, Notes due 2036 consisted of a $ 32 million secured term loan (the “Agemo Term Loan”) and a $ 25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016 and bore interest at 9 % per annum. The Agemo Term Loan had a maturity date of Decemb... | text | 25.0 | monetaryItemType | text: <entity> 25.0 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2022, Notes due 2036 consisted of a $ 32 million secured term loan (the “Agemo Term Loan”) and a $ 25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
As of December 31, 2022, Notes due 2036 consisted of a $ 32 million secured term loan (the “Agemo Term Loan”) and a $ 25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016 and bore interest at 9 % per annum. The Agemo Term Loan had a maturity date of Decemb... | text | 9 | percentItemType | text: <entity> 9 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2022, Notes due 2036 consisted of a $ 32 million secured term loan (the “Agemo Term Loan”) and a $ 25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016 and... | us-gaap:InvestmentInterestRate |
As of December 31, 2022, Notes due 2036 consisted of a $ 32 million secured term loan (the “Agemo Term Loan”) and a $ 25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016 and bore interest at 9 % per annum. The Agemo Term Loan had a maturity date of Decemb... | text | 7 | percentItemType | text: <entity> 7 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2022, Notes due 2036 consisted of a $ 32 million secured term loan (the “Agemo Term Loan”) and a $ 25.0 million secured working capital loan (the “Agemo WC Loan”) with Agemo. The Agemo Term Loan was acquired in 2016 and... | us-gaap:InvestmentInterestRate |
As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, Agemo did not pay contractual rent and interest due under its lease and loan agreements throughout 2022. The loans are on non-accrual status and are accounted for under the cost recovery method and whereby any interest and fee... | text | 10.8 | monetaryItemType | text: <entity> 10.8 </entity> <entity type> monetaryItemType </entity type> <context> As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, Agemo did not pay contractual rent and interest due under its lease and loan agreements throughout 2022. The loans are on non-accrual status... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo loans. Under the restructuring agreement, previously written off contractual unpaid i... | text | 32.0 | monetaryItemType | text: <entity> 32.0 </entity> <entity type> monetaryItemType </entity type> <context> As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo loans. Under the restructuring agreement, previously written off contractual unpaid i... | text | 50.2 | monetaryItemType | text: <entity> 50.2 </entity> <entity type> monetaryItemType </entity type> <context> As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo loans. Under the restructuring agreement, previously written off contractual unpaid i... | text | 5.63 | percentItemType | text: <entity> 5.63 </entity> <entity type> percentItemType </entity type> <context> As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo ... | us-gaap:InvestmentInterestRate |
As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo loans. Under the restructuring agreement, previously written off contractual unpaid i... | text | 5.71 | percentItemType | text: <entity> 5.71 </entity> <entity type> percentItemType </entity type> <context> As discussed in Note 5 – Contractual Receivables and Other Receivables and Lease Inducements, in the first quarter of 2023, Omega entered into a restructuring agreement and a replacement loan agreement that modified the existing Agemo ... | us-gaap:InvestmentInterestRate |
Prior to the restructuring, the principal of the Agemo WC Loan and the Agemo Term Loan were written down to $ 5.9 million and zero , respectively, the fair value of the underlying collateral of these loans. No changes to the collateral supporting the loans were made because of the refinancing of these loans into the Ag... | text | 25.2 | monetaryItemType | text: <entity> 25.2 </entity> <entity type> monetaryItemType </entity type> <context> Prior to the restructuring, the principal of the Agemo WC Loan and the Agemo Term Loan were written down to $ 5.9 million and zero , respectively, the fair value of the underlying collateral of these loans. No changes to the collatera... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Prior to the restructuring, the principal of the Agemo WC Loan and the Agemo Term Loan were written down to $ 5.9 million and zero , respectively, the fair value of the underlying collateral of these loans. No changes to the collateral supporting the loans were made because of the refinancing of these loans into the Ag... | text | 25.2 | monetaryItemType | text: <entity> 25.2 </entity> <entity type> monetaryItemType </entity type> <context> Prior to the restructuring, the principal of the Agemo WC Loan and the Agemo Term Loan were written down to $ 5.9 million and zero , respectively, the fair value of the underlying collateral of these loans. No changes to the collatera... | us-gaap:FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease |
Agemo exercised its option to defer the interest payments due on April 1, 2023 and resumed making interest payments in May 2023 in accordance with the restructuring terms discussed above. During the years ended December 31, 2024 and 2023, we received $ 4.7 million and $ 3.2 million of interest payments from Agemo that ... | text | 73.1 | monetaryItemType | text: <entity> 73.1 </entity> <entity type> monetaryItemType </entity type> <context> Agemo exercised its option to defer the interest payments due on April 1, 2023 and resumed making interest payments in May 2023 in accordance with the restructuring terms discussed above. During the years ended December 31, 2024 and 2... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Agemo exercised its option to defer the interest payments due on April 1, 2023 and resumed making interest payments in May 2023 in accordance with the restructuring terms discussed above. During the years ended December 31, 2024 and 2023, we received $ 4.7 million and $ 3.2 million of interest payments from Agemo that ... | text | 70.9 | monetaryItemType | text: <entity> 70.9 </entity> <entity type> monetaryItemType </entity type> <context> Agemo exercised its option to defer the interest payments due on April 1, 2023 and resumed making interest payments in May 2023 in accordance with the restructuring terms discussed above. During the years ended December 31, 2024 and 2... | us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest |
In December 2023, the Company entered into a $ 50.0 million secured term loan with a principal of an operator that bears interest at a fixed rate of 11 % per annum and matures on December 19, 2026 . In connection with entering into this loan, we also entered into two lease amendments to extend the term of two leases wi... | text | 50.0 | monetaryItemType | text: <entity> 50.0 </entity> <entity type> monetaryItemType </entity type> <context> In December 2023, the Company entered into a $ 50.0 million secured term loan with a principal of an operator that bears interest at a fixed rate of 11 % per annum and matures on December 19, 2026 . In connection with entering into th... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
In December 2023, the Company entered into a $ 50.0 million secured term loan with a principal of an operator that bears interest at a fixed rate of 11 % per annum and matures on December 19, 2026 . In connection with entering into this loan, we also entered into two lease amendments to extend the term of two leases wi... | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> In December 2023, the Company entered into a $ 50.0 million secured term loan with a principal of an operator that bears interest at a fixed rate of 11 % per annum and matures on December 19, 2026 . In connection with entering into this ... | us-gaap:InvestmentInterestRate |
In December 2023, the Company entered into a $ 50.0 million secured term loan with a principal of an operator that bears interest at a fixed rate of 11 % per annum and matures on December 19, 2026 . In connection with entering into this loan, we also entered into two lease amendments to extend the term of two leases wi... | text | 47.1 | monetaryItemType | text: <entity> 47.1 </entity> <entity type> monetaryItemType </entity type> <context> In December 2023, the Company entered into a $ 50.0 million secured term loan with a principal of an operator that bears interest at a fixed rate of 11 % per annum and matures on December 19, 2026 . In connection with entering into th... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Notes due 2025 - 2029 consist of 11 loans with the same operator, the majority of which are primarily short-term revolving lines of credit that are collateralized by the accounts receivable of certain operations of the operator. During the second quarter of 2024, the most significant loan with this operator, which was ... | text | 35.6 | monetaryItemType | text: <entity> 35.6 </entity> <entity type> monetaryItemType </entity type> <context> Notes due 2025 - 2029 consist of 11 loans with the same operator, the majority of which are primarily short-term revolving lines of credit that are collateralized by the accounts receivable of certain operations of the operator. Durin... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
Notes due 2025 - 2029 consist of 11 loans with the same operator, the majority of which are primarily short-term revolving lines of credit that are collateralized by the accounts receivable of certain operations of the operator. During the second quarter of 2024, the most significant loan with this operator, which was ... | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> Notes due 2025 - 2029 consist of 11 loans with the same operator, the majority of which are primarily short-term revolving lines of credit that are collateralized by the accounts receivable of certain operations of the operator. During t... | us-gaap:InvestmentInterestRate |
During the second quarter of 2023, we entered into two $ 15.0 million mezzanine loans with the same operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia (discussed in Note 7 – Real Estate Loans Receivable). The first $ 15.0 million mezzanine loan (the “2028 Mezz Loan”) m... | text | 15.0 | monetaryItemType | text: <entity> 15.0 </entity> <entity type> monetaryItemType </entity type> <context> During the second quarter of 2023, we entered into two $ 15.0 million mezzanine loans with the same operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia (discussed in Note 7 – Real Esta... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
During the second quarter of 2023, we entered into two $ 15.0 million mezzanine loans with the same operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia (discussed in Note 7 – Real Estate Loans Receivable). The first $ 15.0 million mezzanine loan (the “2028 Mezz Loan”) m... | text | 13 | integerItemType | text: <entity> 13 </entity> <entity type> integerItemType </entity type> <context> During the second quarter of 2023, we entered into two $ 15.0 million mezzanine loans with the same operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia (discussed in Note 7 – Real Estate ... | us-gaap:NumberOfRealEstateProperties |
During the second quarter of 2023, we entered into two $ 15.0 million mezzanine loans with the same operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia (discussed in Note 7 – Real Estate Loans Receivable). The first $ 15.0 million mezzanine loan (the “2028 Mezz Loan”) m... | text | 8.6 | percentItemType | text: <entity> 8.6 </entity> <entity type> percentItemType </entity type> <context> During the second quarter of 2023, we entered into two $ 15.0 million mezzanine loans with the same operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia (discussed in Note 7 – Real Estate... | us-gaap:LoansReceivableBasisSpreadOnVariableRate |
During the second quarter of 2023, we entered into two $ 15.0 million mezzanine loans with the same operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia (discussed in Note 7 – Real Estate Loans Receivable). The first $ 15.0 million mezzanine loan (the “2028 Mezz Loan”) m... | text | 12 | percentItemType | text: <entity> 12 </entity> <entity type> percentItemType </entity type> <context> During the second quarter of 2023, we entered into two $ 15.0 million mezzanine loans with the same operator and its affiliates in connection with the operator’s acquisition of 13 SNFs in West Virginia (discussed in Note 7 – Real Estate ... | us-gaap:InvestmentInterestRate |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The lo... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 7.5 | percentItemType | text: <entity> 7.5 </entity> <entity type> percentItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The lo... | us-gaap:InvestmentInterestRate |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 48 | monetaryItemType | text: <entity> 48 </entity> <entity type> monetaryItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The lo... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 55 | monetaryItemType | text: <entity> 55 </entity> <entity type> monetaryItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The lo... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 55.0 | monetaryItemType | text: <entity> 55.0 </entity> <entity type> monetaryItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The ... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 45.0 | monetaryItemType | text: <entity> 45.0 </entity> <entity type> monetaryItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The ... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 8 | percentItemType | text: <entity> 8 </entity> <entity type> percentItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan... | us-gaap:InvestmentInterestRate |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 9 | percentItemType | text: <entity> 9 </entity> <entity type> percentItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan... | us-gaap:InvestmentInterestRate |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loa... | us-gaap:InvestmentInterestRate |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 15.0 | monetaryItemType | text: <entity> 15.0 </entity> <entity type> monetaryItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The ... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The loan is collateralized by the assets of the principal and is cross-collateralized with... | text | 12.5 | percentItemType | text: <entity> 12.5 </entity> <entity type> percentItemType </entity type> <context> On July 8, 2019, the Company entered into a $ 15 million unsecured revolving credit facility agreement with a principal of an operator that bore interest at a fixed rate of 7.5 % per annum and originally matured on July 8, 2022 . The l... | us-gaap:InvestmentInterestRate |
On September 1, 2021, we entered into an $ 8.3 million term loan with LaVie. This term loan bore interest at a fixed rate of 7 % per annum, originally matured on March 31, 2031 and required monthly principal payments of $ 0.1 million commencing September 1, 2022. The loan is secured by a guarantee from LaVie’s parent e... | text | 8.3 | monetaryItemType | text: <entity> 8.3 </entity> <entity type> monetaryItemType </entity type> <context> On September 1, 2021, we entered into an $ 8.3 million term loan with LaVie. This term loan bore interest at a fixed rate of 7 % per annum, originally matured on March 31, 2031 and required monthly principal payments of $ 0.1 million c... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On September 1, 2021, we entered into an $ 8.3 million term loan with LaVie. This term loan bore interest at a fixed rate of 7 % per annum, originally matured on March 31, 2031 and required monthly principal payments of $ 0.1 million commencing September 1, 2022. The loan is secured by a guarantee from LaVie’s parent e... | text | 7 | percentItemType | text: <entity> 7 </entity> <entity type> percentItemType </entity type> <context> On September 1, 2021, we entered into an $ 8.3 million term loan with LaVie. This term loan bore interest at a fixed rate of 7 % per annum, originally matured on March 31, 2031 and required monthly principal payments of $ 0.1 million comm... | us-gaap:InvestmentInterestRate |
On March 25, 2022, we entered into a $ 25.0 million term loan with LaVie that bore interest at a fixed rate of 8.5 % per annum and originally matured on March 31, 2032 . This term loan required quarterly principal payments of $ 1.3 million commencing January 1, 2028 and is secured by a second priority lien on the opera... | text | 25.0 | monetaryItemType | text: <entity> 25.0 </entity> <entity type> monetaryItemType </entity type> <context> On March 25, 2022, we entered into a $ 25.0 million term loan with LaVie that bore interest at a fixed rate of 8.5 % per annum and originally matured on March 31, 2032 . This term loan required quarterly principal payments of $ 1.3 mi... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On March 25, 2022, we entered into a $ 25.0 million term loan with LaVie that bore interest at a fixed rate of 8.5 % per annum and originally matured on March 31, 2032 . This term loan required quarterly principal payments of $ 1.3 million commencing January 1, 2028 and is secured by a second priority lien on the opera... | text | 8.5 | percentItemType | text: <entity> 8.5 </entity> <entity type> percentItemType </entity type> <context> On March 25, 2022, we entered into a $ 25.0 million term loan with LaVie that bore interest at a fixed rate of 8.5 % per annum and originally matured on March 31, 2032 . This term loan required quarterly principal payments of $ 1.3 mill... | us-gaap:InvestmentInterestRate |
During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, remove the requirement to make any principal payments until the maturity dates and to ... | text | 2 | percentItemType | text: <entity> 2 </entity> <entity type> percentItemType </entity type> <context> During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, remo... | us-gaap:InvestmentInterestRate |
During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, remove the requirement to make any principal payments until the maturity dates and to ... | text | 7.5 | monetaryItemType | text: <entity> 7.5 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, r... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, remove the requirement to make any principal payments until the maturity dates and to ... | text | 8.3 | monetaryItemType | text: <entity> 8.3 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, r... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, remove the requirement to make any principal payments until the maturity dates and to ... | text | 15.8 | monetaryItemType | text: <entity> 15.8 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, ... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, remove the requirement to make any principal payments until the maturity dates and to ... | text | 25.0 | monetaryItemType | text: <entity> 25.0 </entity> <entity type> monetaryItemType </entity type> <context> During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, ... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, remove the requirement to make any principal payments until the maturity dates and to ... | text | 11 | integerItemType | text: <entity> 11 </entity> <entity type> integerItemType </entity type> <context> During the fourth quarter of 2022, we amended these loans with LaVie to, among other terms, extend the loan maturities to November 30, 2036 to align with the lease term, and starting in January 2023, reduce the interest rates to 2 %, rem... | us-gaap:NumberOfRealEstateProperties |
On June 2 and 3, 2024, LaVie commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code in the Bankruptcy Court. As described in LaVie’s filings with the Bankruptcy Court, we provided $ 10.0 million of DIP financing to LaVie in order to support sufficient liquidity to, among other things, effectively operat... | text | 10.0 | monetaryItemType | text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> On June 2 and 3, 2024, LaVie commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code in the Bankruptcy Court. As described in LaVie’s filings with the Bankruptcy Court, we provided $ 10.0 million of DIP financing to LaV... | us-gaap:DebtorInPossessionFinancingAmountArranged |
On June 2 and 3, 2024, LaVie commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code in the Bankruptcy Court. As described in LaVie’s filings with the Bankruptcy Court, we provided $ 10.0 million of DIP financing to LaVie in order to support sufficient liquidity to, among other things, effectively operat... | text | 10.0 | percentItemType | text: <entity> 10.0 </entity> <entity type> percentItemType </entity type> <context> On June 2 and 3, 2024, LaVie commenced voluntary cases under Chapter 11 of the U.S. Bankruptcy Code in the Bankruptcy Court. As described in LaVie’s filings with the Bankruptcy Court, we provided $ 10.0 million of DIP financing to LaVi... | us-gaap:DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding |
Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstanding principal of $ 4.5 million as of June 30, 2024, we reserved $ 4.2 million through t... | text | 4.5 | monetaryItemType | text: <entity> 4.5 </entity> <entity type> monetaryItemType </entity type> <context> Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstandin... | us-gaap:DebtorInPossessionFinancingBorrowingsOutstanding |
Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstanding principal of $ 4.5 million as of June 30, 2024, we reserved $ 4.2 million through t... | text | 4.2 | monetaryItemType | text: <entity> 4.2 </entity> <entity type> monetaryItemType </entity type> <context> Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstandin... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstanding principal of $ 4.5 million as of June 30, 2024, we reserved $ 4.2 million through t... | text | 25.0 | monetaryItemType | text: <entity> 25.0 </entity> <entity type> monetaryItemType </entity type> <context> Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstandi... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstanding principal of $ 4.5 million as of June 30, 2024, we reserved $ 4.2 million through t... | text | 3.6 | monetaryItemType | text: <entity> 3.6 </entity> <entity type> monetaryItemType </entity type> <context> Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstandin... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstanding principal of $ 4.5 million as of June 30, 2024, we reserved $ 4.2 million through t... | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstandin... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstanding principal of $ 4.5 million as of June 30, 2024, we reserved $ 4.2 million through t... | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> Given the risks associated with the bankruptcy process, we elected to evaluate the risk of loss on the DIP loan on an individual basis. As the fair value of the collateral available to Omega was estimated to be less than the outstandin... | us-gaap:PaymentsToAcquireLoansReceivable |
As of December 31, 2024, the amortized cost basis of the three LaVie loans was $ 38.3 million, which represents 8.4 % of the total amortized cost basis of all non-real estate loan receivables. The total reserve as of December 31, 2024 related to the LaVie loans was $ 38.3 million. | text | 38.3 | monetaryItemType | text: <entity> 38.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the amortized cost basis of the three LaVie loans was $ 38.3 million, which represents 8.4 % of the total amortized cost basis of all non-real estate loan receivables. The total reserve as of December 31, 2024... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
As of December 31, 2024, the amortized cost basis of the three LaVie loans was $ 38.3 million, which represents 8.4 % of the total amortized cost basis of all non-real estate loan receivables. The total reserve as of December 31, 2024 related to the LaVie loans was $ 38.3 million. | text | 38.3 | monetaryItemType | text: <entity> 38.3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the amortized cost basis of the three LaVie loans was $ 38.3 million, which represents 8.4 % of the total amortized cost basis of all non-real estate loan receivables. The total reserve as of December 31, 2024... | us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest |
In November 2021, we entered into a $ 20.0 million working capital loan (the “$20.0 million WC loan”) with an operator that managed, on an interim basis, the operations of 23 facilities formerly leased to Gulf Coast. The $ 20.0 million WC loan bore interest at 3 % per annum. The maturity date of the $ 20.0 million WC l... | text | 20.0 | monetaryItemType | text: <entity> 20.0 </entity> <entity type> monetaryItemType </entity type> <context> In November 2021, we entered into a $ 20.0 million working capital loan (the “$20.0 million WC loan”) with an operator that managed, on an interim basis, the operations of 23 facilities formerly leased to Gulf Coast. The $ 20.0 millio... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
In November 2021, we entered into a $ 20.0 million working capital loan (the “$20.0 million WC loan”) with an operator that managed, on an interim basis, the operations of 23 facilities formerly leased to Gulf Coast. The $ 20.0 million WC loan bore interest at 3 % per annum. The maturity date of the $ 20.0 million WC l... | text | 23 | integerItemType | text: <entity> 23 </entity> <entity type> integerItemType </entity type> <context> In November 2021, we entered into a $ 20.0 million working capital loan (the “$20.0 million WC loan”) with an operator that managed, on an interim basis, the operations of 23 facilities formerly leased to Gulf Coast. The $ 20.0 million W... | us-gaap:NumberOfRealEstateProperties |
In November 2021, we entered into a $ 20.0 million working capital loan (the “$20.0 million WC loan”) with an operator that managed, on an interim basis, the operations of 23 facilities formerly leased to Gulf Coast. The $ 20.0 million WC loan bore interest at 3 % per annum. The maturity date of the $ 20.0 million WC l... | text | 3 | percentItemType | text: <entity> 3 </entity> <entity type> percentItemType </entity type> <context> In November 2021, we entered into a $ 20.0 million working capital loan (the “$20.0 million WC loan”) with an operator that managed, on an interim basis, the operations of 23 facilities formerly leased to Gulf Coast. The $ 20.0 million WC... | us-gaap:InvestmentInterestRate |
During the year ended December 31, 2022, we recognized provisions for credit losses of $ 5.2 million related to the $ 20.0 million WC loan, which resulted in the loan being fully reserved. Following the sale of 22 facilities, discussed in Note 4 – Assets Held for Sale, Dispositions and Impairments, the remaining accoun... | text | 5.2 | monetaryItemType | text: <entity> 5.2 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, we recognized provisions for credit losses of $ 5.2 million related to the $ 20.0 million WC loan, which resulted in the loan being fully reserved. Following the sale of 22 facilities, discussed... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
During the year ended December 31, 2022, we recognized provisions for credit losses of $ 5.2 million related to the $ 20.0 million WC loan, which resulted in the loan being fully reserved. Following the sale of 22 facilities, discussed in Note 4 – Assets Held for Sale, Dispositions and Impairments, the remaining accoun... | text | 20.0 | monetaryItemType | text: <entity> 20.0 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, we recognized provisions for credit losses of $ 5.2 million related to the $ 20.0 million WC loan, which resulted in the loan being fully reserved. Following the sale of 22 facilities, discusse... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
During the year ended December 31, 2022, we recognized provisions for credit losses of $ 5.2 million related to the $ 20.0 million WC loan, which resulted in the loan being fully reserved. Following the sale of 22 facilities, discussed in Note 4 – Assets Held for Sale, Dispositions and Impairments, the remaining accoun... | text | 0.8 | monetaryItemType | text: <entity> 0.8 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, we recognized provisions for credit losses of $ 5.2 million related to the $ 20.0 million WC loan, which resulted in the loan being fully reserved. Following the sale of 22 facilities, discussed... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
In October 2021, we provided a $ 25.0 million senior secured DIP facility (the “DIP Facility”) to Gulf Coast, in order to provide liquidity for the operations of the Gulf Coast facilities during its Chapter 11 cases. Given the uncertainty and complexity surrounding the bankruptcy process and the deteriorated credit of ... | text | 25.0 | monetaryItemType | text: <entity> 25.0 </entity> <entity type> monetaryItemType </entity type> <context> In October 2021, we provided a $ 25.0 million senior secured DIP facility (the “DIP Facility”) to Gulf Coast, in order to provide liquidity for the operations of the Gulf Coast facilities during its Chapter 11 cases. Given the uncerta... | us-gaap:DebtorInPossessionFinancingAmountArranged |
During the year ended December 31, 2022, we recorded an additional net provision for credit losses of $ 0.2 million related to the DIP Facility, which reflects the full reserve of additional advances of $ 2.2 million made under the facility during 2022 and a $ 2.0 million recovery for interest and fee payments received... | text | 0.2 | monetaryItemType | text: <entity> 0.2 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, we recorded an additional net provision for credit losses of $ 0.2 million related to the DIP Facility, which reflects the full reserve of additional advances of $ 2.2 million made under the fac... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
During the year ended December 31, 2022, we recorded an additional net provision for credit losses of $ 0.2 million related to the DIP Facility, which reflects the full reserve of additional advances of $ 2.2 million made under the facility during 2022 and a $ 2.0 million recovery for interest and fee payments received... | text | 5.3 | monetaryItemType | text: <entity> 5.3 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, we recorded an additional net provision for credit losses of $ 0.2 million related to the DIP Facility, which reflects the full reserve of additional advances of $ 2.2 million made under the fac... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
During the year ended December 31, 2022, we recorded an additional net provision for credit losses of $ 0.2 million related to the DIP Facility, which reflects the full reserve of additional advances of $ 2.2 million made under the facility during 2022 and a $ 2.0 million recovery for interest and fee payments received... | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, we recorded an additional net provision for credit losses of $ 0.2 million related to the DIP Facility, which reflects the full reserve of additional advances of $ 2.2 million made under the fac... | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum principal of $ 20 million, reduced the interest rate to 5 % for the first year and ... | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum principal of $ 20 million, reduced the interest rate to 5 % for the first year and ... | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum principal of $ 20 million, reduced the interest rate to 5 % for the first year and ... | text | 5 | percentItemType | text: <entity> 5 </entity> <entity type> percentItemType </entity type> <context> On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum p... | us-gaap:InvestmentInterestRate |
On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum principal of $ 20 million, reduced the interest rate to 5 % for the first year and ... | text | 6 | percentItemType | text: <entity> 6 </entity> <entity type> percentItemType </entity type> <context> On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum p... | us-gaap:InvestmentInterestRate |
On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum principal of $ 20 million, reduced the interest rate to 5 % for the first year and ... | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum principal of $ 20 million, reduced the interest rate to 5 % for the first year and ... | text | 8.5 | percentItemType | text: <entity> 8.5 </entity> <entity type> percentItemType </entity type> <context> On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum... | us-gaap:InvestmentInterestRate |
On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maximum principal of $ 20 million, reduced the interest rate to 5 % for the first year and ... | text | 23.6 | monetaryItemType | text: <entity> 23.6 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2021, the Company amended the terms of a $ 15 million revolving credit facility with an operator that was previously issued in December 2020 and had a maturity date of December 1, 2022 . The amendment increased the maxim... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on September 30, 2027 . All three loans require quarterly principal payments commencing on Ja... | text | 17.0 | monetaryItemType | text: <entity> 17.0 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on Sept... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on September 30, 2027 . All three loans require quarterly principal payments commencing on Ja... | text | 2.5 | monetaryItemType | text: <entity> 2.5 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on Septe... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on September 30, 2027 . All three loans require quarterly principal payments commencing on Ja... | text | 0.5 | monetaryItemType | text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on Septe... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on September 30, 2027 . All three loans require quarterly principal payments commencing on Ja... | text | 9 | percentItemType | text: <entity> 9 </entity> <entity type> percentItemType </entity type> <context> In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on Septembe... | us-gaap:InvestmentInterestRate |
In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on September 30, 2027 . All three loans require quarterly principal payments commencing on Ja... | text | 14.7 | monetaryItemType | text: <entity> 14.7 </entity> <entity type> monetaryItemType </entity type> <context> In the fourth quarter of 2022, the Company entered into three unsecured loans with a principal of an operator with principal amounts of $ 17.0 million, $ 2.5 million and $ 0.5 million. The loans bear interest at 9 % and mature on Sept... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $ 10.0 million mezzanine loan matures on June 30, 2028 and bears interest at a fixed r... | text | 10.0 | monetaryItemType | text: <entity> 10.0 </entity> <entity type> monetaryItemType </entity type> <context> On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The ... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $ 10.0 million mezzanine loan matures on June 30, 2028 and bears interest at a fixed r... | text | 11 | percentItemType | text: <entity> 11 </entity> <entity type> percentItemType </entity type> <context> On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $ 1... | us-gaap:InvestmentInterestRate |
On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $ 10.0 million mezzanine loan matures on June 30, 2028 and bears interest at a fixed r... | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $ 1... | us-gaap:InvestmentInterestRate |
On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $ 10.0 million mezzanine loan matures on June 30, 2028 and bears interest at a fixed r... | text | 34.0 | monetaryItemType | text: <entity> 34.0 </entity> <entity type> monetaryItemType </entity type> <context> On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The ... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $ 10.0 million mezzanine loan matures on June 30, 2028 and bears interest at a fixed r... | text | 20.0 | monetaryItemType | text: <entity> 20.0 </entity> <entity type> monetaryItemType </entity type> <context> On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The ... | us-gaap:InvestmentOwnedUnderlyingFaceAmountAtMarketValue |
On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $ 10.0 million mezzanine loan matures on June 30, 2028 and bears interest at a fixed r... | text | 7.7 | monetaryItemType | text: <entity> 7.7 </entity> <entity type> monetaryItemType </entity type> <context> On June 30, 2023, the Company entered into a $ 10.0 million mezzanine loan and a revolving working capital loan with an existing operator in connection with the operator’s acquisition of a portfolio of facilities in Pennsylvania. The $... | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to direct the activities that most significantly impact the joint venture’s economic perform... | text | 7.7 | monetaryItemType | text: <entity> 7.7 </entity> <entity type> monetaryItemType </entity type> <context> We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to dire... | us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment |
We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to direct the activities that most significantly impact the joint venture’s economic perform... | text | 24.3 | monetaryItemType | text: <entity> 24.3 </entity> <entity type> monetaryItemType </entity type> <context> We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to dir... | us-gaap:Assets |
We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to direct the activities that most significantly impact the joint venture’s economic perform... | text | 27.9 | monetaryItemType | text: <entity> 27.9 </entity> <entity type> monetaryItemType </entity type> <context> We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to dir... | us-gaap:Assets |
We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to direct the activities that most significantly impact the joint venture’s economic perform... | text | 20.8 | monetaryItemType | text: <entity> 20.8 </entity> <entity type> monetaryItemType </entity type> <context> We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to dir... | us-gaap:Liabilities |
We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to direct the activities that most significantly impact the joint venture’s economic perform... | text | 20.7 | monetaryItemType | text: <entity> 20.7 </entity> <entity type> monetaryItemType </entity type> <context> We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to dir... | us-gaap:Liabilities |
We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to direct the activities that most significantly impact the joint venture’s economic perform... | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> We own a partial equity interest in a joint venture that we have determined is a VIE. We have consolidated this VIE because we have concluded that we are the primary beneficiary of this VIE based on a combination of our ability to dire... | us-gaap:MinorityInterestInJointVentures |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 1026 | integerItemType | text: <entity> 1026 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities,... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 42 | integerItemType | text: <entity> 42 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, l... | us-gaap:NumberOfStatesInWhichEntityOperates |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 98 | percentItemType | text: <entity> 98 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, l... | us-gaap:ConcentrationRiskPercentage1 |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 589 | integerItemType | text: <entity> 589 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, ... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 290 | integerItemType | text: <entity> 290 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, ... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 19 | integerItemType | text: <entity> 19 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, l... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 18 | integerItemType | text: <entity> 18 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, l... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, ... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 52 | integerItemType | text: <entity> 52 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, l... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 43 | integerItemType | text: <entity> 43 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, l... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 12 | integerItemType | text: <entity> 12 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, l... | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 485.5 | monetaryItemType | text: <entity> 485.5 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilitie... | us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities, located in 42 states and the U.K. and operated by 87 third-party operators. Our inve... | text | 88.7 | monetaryItemType | text: <entity> 88.7 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 1,026 healthcare facilities... | us-gaap:EquityMethodInvestments |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.